On the other hand, single‐nucleotide polymorphisms (SNPs) in TACC2 were significantly associated with a risk of low‐grade breast cancer 25, and TACC2 mRNA expression was significantly correlated with shorter disease‐free survival of breast carcinomas patients 12. This evidence concerns the gene TACC2 and breast carcinoma.